The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Randomized Controlled Clinical Trial of Surgery Versus No Surgery in Patients with Mild Asymptomatic Primary Hyperparathyroidism
Abstract
Parathyroidectomy is the definitive therapy for patients with symptomatic primary hyperparathyroidism. However, the role of surgery in mild asymptomatic primary hyperparathyroidism remains controversial. Accordingly, we conducted a prospective, randomized, controlled clinical trial of parathyroidectomy to determine the benefits of surgery vs. adverse effects of no surgery. Fifty-three patients were randomly assigned to either parathyroidectomy (n = 25) or regular follow-up (n = 28). Bone mineral density (BMD), biochemical indices of the disease, quality of life, and psychological function were measured at 6- or 12-month intervals for at least 24 months. Twenty-three of the 25 patients randomized to parathyroidectomy had surgery within the specified time of the protocol and three of the 28 patients randomized to regular follow-up had parathyroidectomy during follow-up. After parathyroidectomy, there was an increase in BMD of the spine (1.2%/yr, P < 0.001), femoral neck (0.4%/yr, P = 0.031), total hip (0.3%/yr, P = 0.07), and forearm (0.4%/yr, P < 0.001) and an expected fall in serum total and ionized calcium, serum PTH, and urine calcium (P < 0.001 for all). In contrast, patients followed up without surgery lost BMD at the femoral neck (-0.4%/yr, P = 0.117) and total hip (-0.6%/yr, P = 0.007) but gained at the spine (0.5%/yr; P = ns) and forearm (0.2%/yr, P = 0.047), with no significant changes in biochemical indices of disease. Consequently, a significant effect of parathyroidectomy on BMD was evident only at the femoral neck (a group difference of 0.8%/yr; P = 0.01) and total hip (a group difference of 1.0%/yr; P = 0.001) but not at the spine (a group difference of 0.6%/yr) or forearm (a group difference of 0.2%/yr). Quality-of-life scores as measured by a 36-item short-form health survey showed significant declines in five of the nine domains (social functioning, physical problem, emotional problem, energy, and health perception) in patients followed up without surgery but in only one of the nine domains (physical function) in the patients who had parathyroidectomy. Consequently, a modest measurable benefit of parathyroidectomy was evident in social and emotional role function (P = 0.007 and 0.012, respectively). Psychological function as assessed by the symptom checklist revised did not change significantly in either group, except for a significant decline in anxiety (P = 0.003) and phobia (P = 0.024) in patients who had surgery in comparison with those who did not. We conclude that it is feasible to conduct a randomized, controlled clinical trial of parathyroidectomy in patients with mild asymptomatic primary hyperparathyroidism, and measurable benefits of surgery on BMD, quality of life, and psychological function can be demonstrated. However, the small but significant benefits of parathyroidectomy must be weighed against the risks of surgery in these otherwise healthy individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed · Cited by 33,716
MCHORNEY, C. A., JOHNE, W., & ANASTASIAE, R. (1993) · Medical Care · doi:10.1097/00005650-199303000-00006 · Cited by 6,681
The SCL-90 and the MMPI: A Step in the Validation of a New Self-Report Scale
Derogatis, L. R., Rickels, K., & Rock, A. F. (1976) · British Journal of Psychiatry · doi:10.1192/bjp.128.3.280 · Cited by 2,298 · cited 5×
“A favorable effect of surgery was seen in two of the nine dimensions of the SCL-90R psychological scores (Fig.”
MethodInfluentialBilezikian, J. P., Potts, J. T., Fuleihan, G. E.-H., Kleerekoper, M., Neer, R., Peacock, M., Rastad, J., Silverberg, S. J., Udelsman, R., & Wells, S. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021370 · Cited by 770
A 10-Year Prospective Study of Primary Hyperparathyroidism with or without Parathyroid Surgery
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001133420221 · Cited by 685
Burton, P., Gurrin, L., & Sly, P. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980615)17:11<1261::aid-sim846>3.0.co;2-z · Cited by 635
The Parathyroid Glands and Metabolic Bone Disease: Selected Studies
(1949) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1949.02900460063033 · Cited by 513
Taylor, K. M., Margolese, R. G., & Soskolne, C. L. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405243102106 · Cited by 407
Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism
Silverberg, S. J., Locker, F. G., Jacobs, T. P., Shane, E. J., Siris, E. S., Staron, R. B., McMahon, D. J., & Bilezikian, J. P. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7883824 · Cited by 275
Chan, A. K., Duh, Q.-Y., Katz, M. H., Slperstein, A. E., & Clark, O. H. (1995) · Annals of Surgery · doi:10.1097/00000658-199509000-00017 · Cited by 270
Cited by
Wilhelm, S. M., Wang, T. S., Ruan, D. T., Lee, J. A., Asa, S. L., Duh, Q.-Y., Doherty, G. M., Herrera, M. F., Pasieka, J. L., Perrier, N. D., et al. (2016) · JAMA Surgery · doi:10.1001/jamasurg.2016.2310 · Cited by 1,343
Silverberg, S. J., Lewiecki, E. M., Mosekilde, L., Peacock, M., & Rubin, M. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1760 · Cited by 688
Bilezikian, J. P., Khan, A. A., Silverberg, S. J., Fuleihan, G. E.-H., Marcocci, C., Minisola, S., Perrier, N., Sitges-Serra, A., Thakker, R. V., Guyatt, G., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4677 · Cited by 602
Rubin, M. R., Bilezikian, J. P., McMahon, D. J., Jacobs, T., Shane, E., Siris, E., Udesky, J., & Silverberg, S. J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1215 · Cited by 593
Walker, M. D., & Silverberg, S. J. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.104 · Cited by 566
Khan, A. A., Hanley, D. A., Rizzoli, R., Bollerslev, J., Young, J. E. M., Rejnmark, L., Thakker, R., D’Amour, P., Paul, T., Van Uum, S., et al. (2017) · Osteoporosis International · doi:10.1007/s00198-016-3716-2 · Cited by 544
Ambrogini, E., Cetani, F., Cianferotti, L., Vignali, E., Banti, C., Viccica, G., Oppo, A., Miccoli, P., Berti, P., Bilezikian, J. P., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0219 · Cited by 404
Silverberg, S. J., Clarke, B. L., Peacock, M., Bandeira, F., Boutroy, S., Cusano, N. E., Dempster, D., Lewiecki, E. M., Liu, J.-M., Minisola, S., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1415 · Cited by 378
Bollerslev, J., Jansson, S., Mollerup, C. L., Nordenström, J., Lundgren, E., Tørring, O., Varhaug, J.-E., Baranowski, M., Aanderud, S., Franco, C., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1836 · Cited by 368
Marcocci, C., & Cetani, F. (2011) · New England Journal of Medicine · doi:10.1056/nejmcp1106636 · Cited by 358
Bilezikian, J. P. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01225 · Cited by 325
Hormones and Disorders of Mineral Metabolism
Bringhurst, F. R., Demay, M. B., & Kronenberg, H. M. (2011) · Williams Textbook of Endocrinology · doi:10.1016/b978-1-4377-0324-5.00028-6 · Cited by 298
Eastell, R., Arnold, A., Brandi, M. L., Brown, E. M., D'Amour, P., Hanley, D. A., Rao, D. S., Rubin, M. R., Goltzman, D., Silverberg, S. J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1758 · Cited by 262
Self-citation
Metadata
- Authors
- Rao, D. S., Phillips, E. R., Divine, G. W., & Talpos, G. B.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-11
- Volume
- 89
- Issue
- 11
- Pages
- 5415-5422
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2146091120
- Cited by
- 378
- References
- 24
- FWCI
- 8.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.